ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "362: A mother’s perspective on Sarepta’s gene therapy halt"
Episode Synopsis
We bring on a mother whose 7-year-old has Duchenne muscular dystrophy, and hear her thoughts on Sarepta’s decision to pull its treatment Elevidys from the market, following a request from the Food and Drug Administration. We also talk about a rare mega-round for a new oncology biotech and an emerging class of drugs aimed at helping people stay awake.
More episodes of the podcast The Readout Loud
382: Biotech's year in review
18/12/2025
In God we trust